This inventor holds 1 USPTO granted patent. Top assignee: Becton Dickinson and Company Limited. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: **Karen Ann Dilly: A Pioneer in Mycobacterial Research**
Introduction
Karen Ann Dilly is an accomplished inventor based in Sparks, MD, USA. She has made significant contributions to the field of microbiology, particularly in the detection and amplification of mycobacterial species. With a focus on innovative techniques, her work has implications for both research and clinical diagnostics.
Latest Patents
Karen holds a patent that revolves around the amplification and detection of Mycobacterium avium complex species. Her patent, titled "Amplification and detection of mycobacterium avium complex species," includes the development of complex-specific amplification primers and methods for enhancing target sequences in the dnaJ genes of the Mycobacterium avium Complex (MAC) species. The disclosed primer target binding sequences are crucial for conducting amplification reactions, allowing for the detection of complex-specific targets and the possible identification of the MAC species from which these targets are derived. Additionally, the patent outlines methods for multiplex amplification, enabling the simultaneous amplification of dnaJ and other targets.
Career Highlights
Karen is affiliated with Becton Dickinson and Company, a leader in medical technology and diagnostics. Through her role, she has been instrumental in advancing methodologies that impact public health through better diagnostics. Her innovative approaches underscore her dedication to scientific research and the importance of her work in laboratory settings.
Collaborations
Throughout her career, Karen has collaborated with notable colleagues such as Silvia A Bustos and Christine Ann Rostkowski. These partnerships have allowed for the pooling of knowledge and expertise, further enhancing the impact of their collective research efforts.
Conclusion
Karen Ann Dilly represents a significant figure in the field of microbiological research and innovation. Her patent advancements in the detection of Mycobacterium avium complex species highlight her commitment to improving diagnostic methodologies. As she continues her work at Becton Dickinson and Company, her contributions are set to leave a lasting legacy in scientific research and public health.